Unite de Fabrication de Medicaments SA (UMED.TN)

Also known as:  Les Laboratoires UNIMED, UNIMED

The Abraaj Group exits Unimed via an IPO on the Tunis Stock Exchange

Tunis, Tunisia, 4 May 2016: The Abraaj Group ('Abraaj' or the 'Group'), a leading investor operating in global growth markets, today announced that it has successfully exited its investment in leading Tunisian pharmaceutical company Unité de fabrication de médicaments ('Unimed' or the 'Company'), through an initial public offering ('IPO') on the Tunis Stock Exchange. The Abraaj Group invested in

Press Release - 04-May-2016

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
Adwya S.A.--
Societe des Industries Pharmaceutiques de Tunisie--
More

Sunday Outlook: World shares fall as markets await Fed meeting

Sunday Outlook: World shares fall as markets await Fed meeting

Gold drops on stronger dollar; oil prices hit

More

Most Viewed Stocks

Stock Screener

More